Compounds > 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole
Page last updated: 2024-08-26

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and 6-ketoprostaglandin f1 alpha

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erl, W; Kruse, HJ; Sellmayer, A; Weber, C; Weber, PC1

Other Studies

1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and 6-ketoprostaglandin f1 alpha

ArticleYear
Platelet activating factor enhances receptor-operated Ca(++)-influx and subsequent prostacyclin synthesis in human endothelial cells.
    Biochemical and biophysical research communications, 1993, Sep-15, Volume: 195, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Fura-2; Histamine; Humans; Imidazoles; Kinetics; Platelet Activating Factor; Platelet Aggregation Inhibitors; Spectrometry, Fluorescence; Thrombin; Umbilical Veins

1993